Effectiveness of using STOPP/START criteria to identify potentially inappropriate medication in people aged ≥ 65 years with chronic kidney disease: a randomized clinical trial
Polypharmacy and inappropriate prescribing are common in elderly with chronic kidney disease (CKD). This study identified potentially inappropriate prescriptions (PIPs) and potential prescribing omissions (PPOs) using the Screening Tool of Older Persons’ Prescriptions (STOPP) and the Screening Tool to Alert doctors to the Right Treatment (START) criteria in elderly with advanced CKD and determined the effect of a medication review on medication adherence and health-related quality of life (HRQoL).
The intervention consisted of a medication review using STOPP/START criteria with a recommendation to a nephrologist or similar review without a recommendation. End points were prevalence of PIP and PPO, medication adherence, and HRQoL. Group differences in outcomes were assessed using a generalized linear mixed model. The trial was registered under www.clinicaltrial.gov (ID: NCT02424786).
We randomized 180 patients with advanced CKD (mean age 77 years, 23% female). The prevalence of PIPs and PPOs in the intervention group was 54% and 50%, respectively. The odds of PPOs were lower in the intervention than the control group (OR 0.42, 95% CI 0.19–0.92, p = 0.032), while there was no intergroup difference in the number of PIPs (OR 0.57, CI 0.27–1.20, p = 0.14). There was no difference in changes in medication adherence or HRQoL from baseline to 6 months between the groups.
The intervention with the STOPP/START criteria identified a high prevalence of inappropriate medications in the elderly with advanced CKD and reduced the number of PPOs. However, there was no detectable impact of the intervention on medication adherence or HRQoL.
KeywordsPolypharmacy Chronic kidney disease Medication adherence Elderly Inappropriate medication
The use of the Morisky Medication Adherence Scale (© MMAS) is protected by US copyright laws. Permission for use is required. A license agreement is available from Donald E. Morisky at firstname.lastname@example.org or MMAS Research LLC 14725 NE 20th ST. Bellevue, WA 98007.
K.P. and K.S. designed the study with support from the other authors. K.P., M.R.N., I.B.E., W.A., and N.v.d.L. participated in screening, recruitment, and data collection. K.S., J.Š.B., and K.P. analyzed the data. K.P. drafted the manuscript with support from K.S. All of the authors contributed to data interpretation, critically reviewed the manuscript, and approved its final version.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent was obtained from all individual participants included in the study.
- 6.Hamilton H, Gallagher P, Ryan C, Byrne S, O'Mahony D (2011) Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 171(11):1013–1019Google Scholar
- 7.Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D (2008) STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 46(2):72–83Google Scholar
- 8.Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC (1991) Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 151(9):1825–1832Google Scholar
- 11.Hill-Taylor B, Walsh KA, Stewart S, Hayden J, Byrne S, Sketris IS (2016) Effectiveness of the STOPP/START (Screening Tool of Older Persons’ potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment) criteria: systematic review and meta-analysis of randomized controlled studies. J Clin Pharm Ther 41(2):158–169PubMedGoogle Scholar
- 14.(2015) American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 63(11):2227–2246Google Scholar
- 15.Strobel C, Engedal K (2008) Norsk revidert Mini Mental Status Evaluering (MMSE-NR). http://www.legeforeningen.no/geriatri
- 16.World Health Organization (2018) Falls. http://www.who.int/news-room/fact-sheets/detail/falls. Accessed 3 June 2019
- 17.Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383Google Scholar
- 20.Berlowitz DR, Foy CG, Kazis LE, Bolin LP, Conroy MB, Fitzpatrick P, Gure TR, Kimmel PL, Kirchner K, Morisky DE, Newman J, Olney C, Oparil S, Pajewski NM, Powell J, Ramsey T, Simmons DL, Snyder J, Supiano MA, Weiner DE, Whittle J, Group SR (2017) Effect of intensive blood-pressure treatment on patient-reported outcomes. N Engl J Med 377(8):733–744PubMedPubMedCentralGoogle Scholar
- 21.Morisky DE, Ang A, Krousel-Wood M, Ward HJ (2008) Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 10(5):348–354Google Scholar
- 26.System USRD (2017) United States Renal Data System. 2017 USRDS annual data report: epidemiology of kidney disease in the United States. Chapter 5: Mortality. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2017. https://www.usrds.org/2018/view/v2_05.aspx. Accessed 13 June 2018
- 27.Gonzalez-Lopez A, Nava-Rebollo A, Chocarro-Martinez A, Andres-Martin B, Santana-Zapatero H, Herrera-Gomez F, Diego-Martin J, Escaja-Muga C, Grande-Villoria J (2019) Potentially inappropriate prescribing in patients on dialysis using STOPP-START criteria. Nefrología (English Edition) 39(1):92–94Google Scholar
- 30.Frankenthal D, Lerman Y, Kalendaryev E, Lerman Y (2014) Intervention with the screening tool of older persons potentially inappropriate prescriptions/screening tool to alert doctors to right treatment criteria in elderly residents of a chronic geriatric facility: a randomized clinical trial. J Am Geriatr Soc 62(9):1658–1665PubMedGoogle Scholar
- 32.Gallagher P, Lang PO, Cherubini A, Topinkova E, Cruz-Jentoft A, Montero Errasquin B, Madlova P, Gasperini B, Baeyens H, Baeyens JP, Michel JP, O'Mahony D (2011) Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol 67(11):1175–1188Google Scholar
- 43.Brown EA, Johansson L, Farrington K, Gallagher H, Sensky T, Gordon F, Da Silva-Gane M, Beckett N, Hickson M (2010) Broadening Options for Long-term Dialysis in the Elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients. Nephrol Dial Transplant 25(11):3755–3763PubMedPubMedCentralGoogle Scholar
- 47.Little RJ, D'Agostino R, Cohen ML, Dickersin K, Emerson SS, Farrar JT, Frangakis C, Hogan JW, Molenberghs G, Murphy SA, Neaton JD, Rotnitzky A, Scharfstein D, Shih WJ, Siegel JP, Stern H (2012) The prevention and treatment of missing data in clinical trials. N Engl J Med 367(14):1355–1360PubMedPubMedCentralGoogle Scholar